evista การใช้

• One panel member called Evista " estrogen light ."
• For that reason, the FDA approved Evista only for osteoporosis.
• Evista's now show only that it builds bone.
• The news gave investors hope that the outlook for Evista would brighten.
• Evista's " side effect profile is very favorable,"
• Some analysts see estimates for Evista sales as overblown.
• Also known as Evista, raloxifene is considered to have fewer side effects.
• Evista generated $ 665 million in sales last year.
• "That's what has happened to Lilly with Evista ."
• Evista : Helps restore estrogen and bone loss.
• The researchers concluded that Evista did not have an overall effect on cognitive function.
• Lilly expects to start sales of a similar drug, Evista, in early 1998.
• Lilly is expected to file this summer for FDA approval for Evista for prevention of osteoporosis.
• Evista prevented bone loss, measured in the spine and hip, according to the study.
• Still, he said Evista has huge potential sales in the largely untapped osteoporosis treatment market.
• Panel members said Evista didn't appear as effective as Premarin in building bone density.
• Evista sales might not have to carry as much slack as some analysts expect, however.
• Raloxifene is marketed by Eli Lilly & Co . under the trade name Evista.
• Evista : www . evista . com
• Evista : www . evista . com